New Guideline 5 Electrophysiological Recording and Stimulation System

BOWDOIN, ME – January 8, 2019 – FHC, Inc., announced today that is has received 510(k) clearance from the Food and Drug Administration (FDA) for the Guideline 4000 5.0™ electrophysiological recording and stimulation system.

BOWDOIN, ME – FHC, Inc., a global manufacturer of products for the neuroscience industry, has announced the internal promotion of two employees.

Exceptional opportunity for an experienced infant care teacher in our employer-based early learning center